Stock PROTAGONIST THERAPEUTICS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Protagonist Therapeutics Inc Nasdaq

Equities

US74366E1029

End-of-day quote Nasdaq
Other stock markets
- PTS - Intraday chart for Protagonist Therapeutics Inc
05-07 Protagonist Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT

Chart calendar Protagonist Therapeutics Inc

9f32f91800349175.z-FOYY_D6yUyf8uXRdzDKtlU0e0lNcpiJrY7WtRdakI._JQGLL7x3RxTLK3QKZOwb4khg4pLWqwvQptqIroZPiyskBYE0IGPFX4HuA~b2fe3d4039e0042ced9c0bdd4ca61c88

Upcoming events on Protagonist Therapeutics Inc

14/06/2024 13:45 European Hematology Association Congress
20/06/2024 18:00 Annual General Meeting
31/07/2024 Q2 2024 Earnings Release (Projected)
05/11/2024 Q3 2024 Earnings Release (Projected)
17/03/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Protagonist Therapeutics Inc

14/05/2024 19:45 Capital One Biotech/Biopharma Disruptors Conference - Panel
13/05/2024 19:00 Citizens JMP Life Sciences Conference - Fireside Chat
08/05/2024 21:05 Q1 2024 Earnings Release
28/03/2024 17:00 H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference
26/03/2024 17:30 Napa Valley Biotech Forum
11/03/2024 Jefferies Biotech on the Bay Summit
10/03/2024 American Academy of Dermatology Meeting
27/02/2024 21:05 Q4 2023 Earnings Release
08/02/2024 14:00 Guggenheim Healthcare Talks Biotechnology Conference
31/01/2024 21:30 Business Update Call
09/01/2024 17:45 JPMorgan Healthcare Conference
11/12/2023 18:30 American Society of Hematology Meeting - Session Name: 634
11/12/2023 02:00 American Society of Hematology Meeting - Session Name: 634
10/12/2023 01:30 American Society of Hematology Meeting - Session Name: 113
09/12/2023 18:30 American Society of Hematology Meeting - Session Name: 904
14/11/2023 09:00 Jefferies London Healthcare Conference - Fireside Chat
09/11/2023 19:25 Truist Securities Healthcare Conference - Panel
06/11/2023 J.P. Morgan Equity Opportunities Forum
06/11/2023 16:10 Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat
02/11/2023 04:00 Q3 2023 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,23
1,74
-86.69%		28,6
25,7
11.45%		27,4
23,2
17.93%		26,6
31,4
-15.46%		60,0
30,0
100%
270

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-63,7
-68,7
7.22%		-125
-135
7.38%		0,00
0,00
- 		-92,7
-96,0
3.46%
82,0

EBIT
Million USD		Released
Forecast
Spread 		-80,5
-81,8
1.55%		-64,5
-65,4
1.29%		-126
-128
1.54%		-131
-125
-5.35%		-93,7
-127
26.5%
80,1

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-77,9
-79,3
1.83%		-64,8
-64,1
-1.11%		-126
-128
2.06%		-127
-127
-0.41%		-79,0
-116
31.76%
95,4

Net income
Million USD		Released
Forecast
Spread 		-77,2
-77,9
0.89%		-66,2
-66,2
0.04%		-126
-128
1.93%		-127
-123
-3.53%		-79,0
-115
31.24%
77,3

EPS
USD		Released
Forecast
Spread 		-2,98
-3,00
0.6%		-1,92
-1,94
0.84%		-2,71
-2,73
0.78%		-2,60
-2,49
-4.44%		-1,39
-2,02
31.28%
1,15

Announcement Date10/03/2010/03/2128/02/2215/03/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		25,7
17,1
50.86%		0,86
0,38
124.09%		0,00
0,00
- 		0,00
5,00
- 		0,00
1,67
- 		0,00
0,00
- 		0,00
0,00
- 		60,0
30,0
100%		255
120
112.46%
6,67


0,83


7,50


0,00


100

EBITDA
Million USD		Released
Forecast
Spread 		-20,9
-50,0
58.28%		-41,2
-52,0
20.8%		-32,0
-43,0
25.5%		-36,3
-33,0
-9.88%		-35,8
-37,0
3.32%		-42,1
-37,0
-13.83%		-38,1
-43,0
11.44%		23,3
21,0
10.94%		207
-38,0
643.54%
-44,0


-45,0


-36,0







EBIT
Million USD		Released
Forecast
Spread 		-21,1
-27,8
24.07%		-41,4
-46,3
10.55%		-32,3
-43,3
25.35%		-36,5
-29,0
-25.97%		-36,0
-36,3
0.65%		-42,4
-36,5
-15.94%		-38,3
-42,6
9.96%		23,0
-10,1
328.49%		206
36,9
458.72%
-39,8


-46,1


-40,3







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,9
-31,6
33.77%		-41,0
-48,9
16.01%		-31,2
-41,7
25.09%		-34,2
-33,6
-1.71%		-33,7
-33,5
-0.69%		-38,5
-35,0
-9.97%		-34,1
-39,7
14.11%		27,3
-8,04
440.04%		211
114
84.39%
-42,9


-43,3


-29,2







Net income
Million USD		Released
Forecast
Spread 		-20,9
-30,4
31.15%		-41,0
-45,9
10.65%		-31,2
-43,0
27.39%		-34,2
-29,4
-16.27%		-33,7
-35,9
6.05%		-38,5
-35,5
-8.2%		-34,1
-40,2
15.17%		27,3
-7,61
459.24%		207
39,3
427.28%
-44,8


-45,0


-37,0







EPS
USD		Released
Forecast
Spread 		-0,43
-0,63
31.57%		-0,84
-0,94
10.17%		-0,64
-0,87
26.31%		-0,69
-0,59
-16.49%		-0,67
-0,73
7.78%		-0,68
-0,65
-5.22%		-0,58
-0,69
16.27%		0,44
-0,14
406.9%		3,26
1,19
173.04%
-0,73


-0,73


-0,60


-0,77


0,62

Announcement Date04/05/2204/08/2208/11/2215/03/2304/05/2303/08/2302/11/2327/02/2407/05/24-----

Upcoming sector events for Protagonist Therapeutics Inc

17/05/2024 07:00 BIOARCTIC AB: Q1 2024 Earnings Release
20/05/2024 ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00 EXSCIENTIA PLC: Q1 2024 Earnings Release
21/05/2024 CUREVAC N.V.: Q1 2024 Earnings Release (Projected)
21/05/2024 EVOTEC SE: Q1 2024 Earnings Release
30/06/2024 IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected)
15/07/2024 06:45 ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Protagonist Therapeutics Inc

Today REPLIMUNE GROUP, INC.: Q4 2024 Earnings Release (Projected)
14/05/2024 GNI GROUP LTD.: Q1 2024 Earnings Release
14/05/2024 21:05 NUVATION BIO INC.: Q1 2024 Earnings Release
14/05/2024 12:30 ABSCI CORPORATION: Q1 2024 Earnings Release
14/05/2024 06:50 BELITE BIO, INC: Q1 2024 Earnings Release
13/05/2024 POLARIS GROUP: Q1 2024 Earnings Release
13/05/2024 21:30 AEROVATE THERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 12:00 APOGEE THERAPEUTICS, INC.: Q1 2024 Earnings Release
13/05/2024 00:00 PRAXIS PRECISION MEDICINES, INC.: Q1 2024 Earnings Release
13/05/2024 11:30 FORTREA HOLDINGS INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Stock
  5. Calendar Protagonist Therapeutics Inc
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019**#ffffff**/services/solutions/**#004eff**#000000**Replicate our performance**1**